HCC CONNECT’s Post

New review from The #FASEBJournal: Targeting KRAS in gynecological malignancies Cervical, endometrial, and ovarian cancers are among the most common gynecological malignancies and while surgery, chemotherapy, and radiotherapy are standard treatments, challenges like relapse and drug resistance persist. KRAS, one of the most frequently mutated oncogenes, plays a pivotal role in these cancers. This comprehensive review explores how KRAS serves as a biomarker and outlines emerging therapeutic strategies targeting the KRAS pathway in gynecological tumors. 📄 Read the full article to dive deeper into potential breakthroughs in cancer treatment: https://hubs.ly/Q02YcdP00 #CancerResearch #GynecologicalCancer #KRAS #Oncology #MedicalResearch #CancerTreatment #FASEB

Did you miss our latest Liver Cancers News? Come read about: 1️⃣ Spotlighting Disparities in Pediatric Liver Cancer Treatment 2️⃣ OU Health Performs Oklahoma’s First Liver #Transplant Surgery to Treat Lethal Form of #Cancer 3️⃣ A New #AI Tool Could Spot #LiverCancer Early, Upping Survival Be sure to read more about these topics and learn about other updates in the field in our Latest Liver Cancer News 👇 https://lnkd.in/gtGQk4dD #LiverHealth #health #liver

Does the addition of the anti-PD-1 antibody serplulimab and anti-VEGF HLX04 (a bevacizumab biosimilar) to XELOX chemotherapy improve progression-free survival in metastatic colorectal cancer? Read the Viewpoint and results of the phase 2 part of the ASTRUM-015 clinical trial, both published in Med by Cell Press. #colorectalcancer #immunotherapy #antiPD1 #antiVEGF #XELOX #PFS #clinicaltrial #ASTRUM015 https://lnkd.in/ePKf9GqC

The most common treatment for cervical cancer that has been diagnosed early is cervical conization to remove the cancerous cells. If your doctor feels that there is a possibility that the cancer cells have spread beyond the cervix, or for patients who are beyond their child-bearing years, a doctor may recommend a hysterectomy to remove the cervix and uterus. While a hysterectomy is a major surgery with a significant recovery period, it is a highly effective way of addressing cervical cancer. Contact Beacon Clinic today with any questions and see how we can help you! 🌐 YourBeaconClinic.com 📲 208.755.2804 . . . #oncology #cancer #health #cancercare #cancertreatment #chemotherapy #medicine #cancersucks #healthcare #cancerresearch #radiation #immunotherapy

Kudos to Mercy surgical oncologists Dr. Armando Sardi and Dr. Vadim Gushchin, as well as Drs. Luis Falla-Zuniga, Sergei Iugai, and Vladislav Kovalik of The Institute for Cancer Care research team as they attend the Advanced Cancer Therapies conference in San Juan, Puerto Rico. There they will present 6 separate projects addressing such issues as Appendiceal Adenocarcinoma and the Role of Systemic Chemotherapy Prior to CRS (Cytoreductive Surgery)/#HIPEC (Hyperthermic or Heated Intraperitoneal #Chemotherapy); Small Bowel Obstruction and #OvarianCancer and patient treatment with and without HIPEC; Systemic Inflammatory Markers as predictors of early morbidity and survival in #appendixcancer patients; and the addition of HIPEC to CRS as safe in appendix or #coloncancer under select conditions.

𝐃𝐚𝐲 𝟓 𝐨𝐟 𝐏𝐫𝐨𝐬𝐭𝐚𝐭𝐞 𝐜𝐚𝐧𝐜𝐞𝐫! 🎗️ As we wrap up our Prostate Cancer Series, it’s time to explore treatment options. 🌟 From hormone therapy to surgery and radiation, knowing these can help you and your doctor choose the best path forward.🧑⚕️🩺 Check out our reel for a snapshot of these treatments and their roles in managing prostate cancer.💡🌟 #zuvius #cancer #CancerAwareness #fightcancer #beatcancer Nimishh Thakkar; Shailesh Shetty; Alka Chavan; Swapnil Kamble

Cancer research is critical, especially when it comes to pancreatic cancer. When surgery is not recommended for a patient with pancreatic cancer, radiation therapy is used to control the disease. The goal of Dr. Nichols' clinical trial is to determine if proton radiation combined with chemotherapy can better control a pancreatic cancer patient's disease so that surgery is then possible. Find out about this clinical trial for pancreatic cancer: https://bit.ly/4ewpLS1 #pancreaticcancer #pancreascancer #PancreaticCancerAwarenessMonth Pancreatic Cancer Action Network #protontherapy #beatcancer

Transarterial radioembolization (TARE) with Yttrium-90 (Y-90) is an innovative and effective treatment approach for liver cancer, particularly hepatocellular carcinoma (HCC) and liver metastases. This minimally invasive procedure delivers high doses of radiation directly to liver tumors while sparing healthy liver tissue, offering a potent and targeted therapeutic option for patients who are not candidates for surgery or other local therapies. To explore the principles, clinical applications, and potential benefits of Y-90 TARE in liver cancer treatment: https://lnkd.in/d2fX6f6w #Yttrium90 #Radioembolization #LiverCancerTreatment #Y90Therapy #medwise #livercancer #livercancertreatment

#ClinicalMonday Exciting Advances in Cancer Treatment! 🚨 A recent clinical trial of vimseltinib, a new tyrosine kinase inhibitor, has shown promising results in treating tenosynovial giant cell tumor (TGCT) – particularly in patients where surgery isn't an option. 🧬 🔑 Key Results: 🔸72% response rate in patients with TGCT. 🔸Well-tolerated with manageable side effects. 🔸Long-lasting responses, with patients on treatment for over 2 years. 🔸With limited options for those not eligible for surgery, vimseltinib represents a breakthrough in TGCT treatment. More research is on the horizon, but these findings highlight the potential for targeted therapies in oncology! 💡Read more here: https://lnkd.in/giXigaXF #CancerResearch #Oncology #ClinicalTrials #TGCT #TargetedTherapy #InnovationInHealthcare

📃Scientific paper: Neoadjuvant chemotherapy for borderline resectable and upfront resectable pancreatic cancer increasing overall survival and disease-free survival? Abstract: OS and DFS (p=<0.001). R0 patients had significantly longer OS (p=0.03) and longer DFS (P=0.08). In the multivariate analysis, the presence of postoperative pancreatic fistula, R1 resection, N+ and not access to adjuvant chemotherapy were bad prognostic factors of OS. Conclusions: Our study suggests the benefits of NAC for BR patients in downstaging tumors and rendering them amenable to resection, with same oncological result compared to US. Continued on ES/IODE ➡️ https://etcse.fr/ZfB ------- If you find this interesting, feel free to follow, comment and share. We need your help to enhance our visibility, so that our platform continues to serve you.